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Abstract 
 Background 
                   Diabetic mellitus is  a  chronic disease in children. Autoimmunity is  
the  principle   etiology  of this disorder.   This is established by presence of 
auto antibodies . There are various autoantibodies like GAD , ICA 512 , 
IAA.There is a wide variation in prevalence of GAD antibodies in various 
population   and there  are few studies in our population  so  we proceeded with 
this study 
 Materials and  methods 
                All newly diagnosed type 1 diabetic children between the  age of 1-
12years attending our diabetic clinic were enrolled in our study. A total of 50 
patients were studied. Diagnosis  was  confirmed by clinical criteria.    Serum 
samples of  them were collected and  analysed  for GAD antibodies by ELISA 
method. HbA1c and insulin requirement was also taken  to compare with 
autoimmunity. 
Results  
              The prevalence of GAD antibodies in our study group was 42% . The 
disease was more prevalent in  children above 10 years.  There was no 
significant metabolic derangements when comparing positivity for GAD 
antibodies. Large sample of patients can be analysed by multicentric  study  
Key word- new onset diabetic children , GAD antibodies, autoimmunity. 
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STUDY ON PREVALENCE OF GAD ANTIBODIES IN 
TYPE 1 DIABETIC CHILDREN  
INTRODUCTION 
Diabetes mellitus is a metabolic disease with derangement of 
glucose metabolism due to reduced insulin secretion or action. It is 
characterised by hyperglycaemia and abnormality in fat and protein 
metabolism . Type 1 diabetes mellitus is more prevalent in children, 
pathogenesis being the autoimmune mediated destruction of beta cells of 
pancreas. 
EPIDEMIOLOGY 
More than 10,000 new cases of Diabetes is being diagnosed every 
year in United States. Incidence is about 1 in every 1500 children <5yrs 
and 1 in 350 in 5 – 18 yrs aged children.(1)  
Incidence of diabetes in south Indian children is 10.5/10,000 /year. 
Corresponding values for boys and girls are 12.6 and 9.6 respectively (2). 
There are two peaks in age of presentation, first at 5 – 7yrs and then at 
puberty. Both sexes are equally affected . There is seasonal variation with 
more cases reported in winter months. Monozygotic twins have a 60% 
2 
 
risk of developing diabetes. In contrast, dizygotic twins have only an 8% 
risk of concordance.(3) 
The risk of diabetes in children with maternal history of diabetes is 
2-3% and 5-6% (3) for children with paternal history of type1DM. But 
85% of children have no family history.  
ETIOLOGY  
HLA /MHC encoded susceptibility to type 1 DM  
In 95%, type1 DM is due to influence of environmental factors 
with increased incidence in genetically susceptible individuals. Evidence 
suggest Human leukocyte antigen (HLA) class II molecules DR3 and 
DR4 are strongly associated with type 1 DM. More than 90% of whites 
with type 1 diabetes mellitus express DR3 compared to 50-60% in the 
general population. Patients expressing DR3 are also at risk for 
developing other autoimmune endocrinopathies and celiac disease . 
Absence of aspartic acid at position 57 within DQ beta chain and absence 
of arginine at 52 in DQ alpha chain increases the risk by 100 times.  
Role of HLA Class1 
HLA complex especially HLA –A and HLA –B have more 
significance. But HLA -39 confers high risk for type 1 DM.  
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PTPN22 (Lymphoid Tyrosine Phosphatase)  
Single nucleotide polymorphisms in the gene located on 
chromosome 1p13 that encodes lymphoid tyrosine phosphatase is 
associated with type1 DM. 
CTLA -4 
Cytotoxic T lymphocyte antigen -4 located on chromosome 2q is 
associated with type 1 DM. 
Interleukin -2 Receptor 
Interleukin -2 receptor SNP near the gene expressing IL-2 receptor 
is associated with diabetes.  
Interleukin -1 Receptor 
Inhibition of activation of IL - 1 receptor is associated with type 1 
DM.  
Interferon induced helicase (4) 
This gene protects the host from viral infections and variation 
results in diabetes, thus demonstrating the role of virus in this disease. 
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CYP27B1 
A subfamily of cytochrome p450, encodes vitamin D 1 alpha 
hydroxylase. This gene is associated with type1DM. Thus demonstrating 
the role of vitamin D in diabetes. 
Autoimmunity 
Development of antibodies and T lymphocytes targeted to beta 
cells and release of cytokines within pancreatic islets results in 
destruction of beta cells. Thus Beta cell destruction is due to combination 
of direct CD8T cell attack and cytotoxity from release of free radicals and 
cytokines like IL-1, TNFα, TNFβ, and IFN gamma released from 
macrophages and T cells . Greater than 80% of patients have beta cell 
antibodies at the time of diagnosis. The autoantibodies in DM includes 
insulin autoantibodies, 65-kd isoform of glutamic acid decarboxylase 
antibodies, insulinoma associated protein - IA2,ICA512 autoantigen. The 
presence of antibodies varies with age and decreases with longer duration 
of disease. Persons with positive ICA and positive family history of 
diabetes have high predilection for developing diabetes. Risk being 
higher in patients with multiple antibodies. 
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Glutamic Acid Decarboxylase  
This 64 kda islet autoantigen is one of the important assay for islet 
autoantibodies. Mapping epitopes recognised by GAD 65 autoantibodies 
indicate that entire surface of molecule is target for GAD autoantibodies. 
This proves GAD 65 is immunogen in beta cell destruction which is 
expressed in all islet cell .Both GAD 65 and GAD 67 present in 
cytoplasmic microvesicles of neurons and in endocrine. GAD 65 is more 
pronounced in females than male in children less than 12 years .GAD 65 
is associated with rapid onset of type 1 diabetes. ‘Prevalence of ICA and 
IAA decreases with increasing age of onset.  
ICA 512 (IA-2beta) 
ICA-512 antibodies homologous to tyrosine phosphatase like 
molecule is expressed in neuronal and endocrinal tissue. Molecules 
associated with islet secretary granules detected by ELISA autoantibodies 
react with intracytoplasmic portion of the molecule then secretory 
granules fuse with plasma membrane. ICA 512 autoantibodies are most 
specific form of antibodies. ICA 512 may be only autoantibody in pre 
diabetic phase 
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Insulinoma Associated Antibodies 
This is a nonspecific antibody directed against beta cell, detected in 
60% of patients. 
Insulin Autoantibodies 
Autoantibody targeted to insulin. It is the only antibody thought to 
be highly specific for beta cells. Detected in about 50% of type 1 diabetic 
children. 
Environmental Factors 
Autoantibodies are detected after mumps, measles, chickenpox, 
coxsackie and rotavirus infection. Breast feeding is protective and early 
exposure to cows milk increases the risk of type 1 DM. Perinatal factors 
like preeclampsia, Lscs, RDS, birth weight, gestational age, birth order 
and maternal age increases the risk. 
Congenital Rubella Syndrome 
Prenatal rubella infection is associated with autoimmunity in 70% 
of children which increases the risk of developing type 1 DM later. 70% 
of children with rubella acquired after birth have no risk.  
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Enteroviruses 
There are case reports which show association between enterovirus 
infection and subsequent development of type 1 diabetes.  
Mumps Virus 
Mumps infection leads to development of beta cell autoimmunity 
with high frequency of type 1 diabetes. 
Immunisation 
Immunisation against mumps and pertusis decreases the risk of 
type 1 diabetes 
Other Autoantibodies 
One fourth of type 1 diabetic patient have thyroid autoantibodies 
especially antibodies against peroxidose or thyroglobulin. They may later 
develop overt disease like hashimotos thyroiditis resulting in 
hypothyroidism. Thus it becomes necessary to do thyroid function test 
yearly once.  
Celiac Disease 
Celiac disease is seen in type 1 diabetic patients and is 
asymptomatic. It is associated with HLA DR3 and DR4 and endomysial 
autoantigen such as tissue transglutaminase. Transglutaminase 
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autoantibody is present in one third of type 1 diabetic patients. Wheat rich 
diet in diabetic patients increases the burden, since celiac disease is an 
immune mediated disorder to gliadin present in wheat.  
Addisons Disease 
Type 1 diabetic patients are prone to develop antibodies to 
21hydrooxylase and thus develop addisons disease. Insulin requirement 
decreases in diabetics with coexistent addisons disease.  
Other Autoimmune Disorders 
Myasthenia gravis, graves disease, juvenile rheumatoid arthritis, 
pernicious anaemia can also occur. 
Autoimmune Poly Endocrine Syndromes 
18 % of patient with autoimmune polyendocrine syndrome -1 
(mucocutaneous candidiasis, addisons disease and hypothyroidism ) 
develop type 1 diabetes, which is more common in patients with glutamic 
acid decarboxylase antibodies.  
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PATHOGENESIS 
Immune dysregulation, influenced by genetic susceptibility and 
environmental modifiers, leads to development of autoantibodies against 
various islet cell components, including glutamic acid decarboxylase 
antibodies (GAD-65), islet cell antibodies (ICA512/IA-2) and insulin 
antibodies (IAA). Presence of multiple autoantibodies is a predictor of 
future DM Primary pathogenesis is Beta cell destruction. It is a T-cell 
mediated process, as evidenced by the presence of intense insulinitis in 
newly diagnosed patients. Rapid destruction occurs in younger 
individuals and slower in older individuals. Autoimmune disorders 
including Graves' disease, Addison's disease and autoimmune 
polyendocrine syndromes are associated with diabetes. 
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Natural history of type 1DM 
 
 
 
 
 
 
 
  
 
 
 
  
Genetic Susceptibility 
Exposure to unknown 
environmental factors 
triggers 
Lack of exposure 
autoimmunity 
Progressive beta cell 
Clinical diabetes 
No autoimmunity 
No diabetes complications 
Clinical remission 
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Pathogenesis of Diabetic ketoacidosis 
Insulin is a anabolic hormone secreted when there is rise in blood 
glucose level. Receptor mediated mechanism allow the uptake of glucose 
into the cell which stimulates glycogen synthesis, inhibits glucogenesis 
and glycogenolysis and increases lipid synthesis from triglycerides and 
glycerol. Insulin favours storage of lipid in adipose tissue, increases 
uptake of amino acid, protein and glycogen synthesis . In absence of 
insulin serum glucose cannot be used by peripheral tissue because of 
dependence of peripheral tissue glucose transporters on insulin. Hepatic 
glycogenolysis and gluconeogenesis are stimulated resulting in 
hyperglycemia. When serum glucose level exceeds renal threshold, 
osmotic diuresis occurs and it leads to significant urinary loses of fluids 
and potassium, sodium, calcium, phosphorus and magnesium. 
Hyperglycemia and reduced peripheral glucose uptake with urinary water 
losses, leads to dehydration and hyperosmolarity. Increased lipolysis in 
adipose tissue,fatty acid oxidation in the liver and proteolysis in muscle 
leads to accumulation of ketones betahydroxybutrate and acetoacetate and 
leads to metabolic acidosis.  
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 INSULIN DEFICIENCY INCREASED SECRETION 
OF COUNTER REGULATORY HORMONE  
HYPERGLYCEMIA 
HYPERKETONEMIA 
OSMOTIC DIURESIS 
FLUID AND ELECTROLYTE 
LOSS 
HYPOVOLUMEIA 
DEHYDRATION 
METABOLIC 
ACIDOSIS 
VOMITTING 
HYPERVENTILLATION 
LACTIC ACIDOSIS 
K+ LOSS FROM 
CELLS 
TISSUE 
ISCHEMIA 
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Classification of Diabetes Mellitus 
Neonatal Diabetes 
Transient 
Permanent  
Genetic Defects in Insulin Action 
Rabson mendenhall syndrome 
Donahue syndrome( Leprechauniusm diabetes) 
Liprotrophic diabete 
Type 1 Diabetes  
Immune mediated 
Slowly progressive type 1 diabetes 
Non Immune Mediated 
Type 2 diabetes 
Monogenic diabetes 
Atypical diabetes 
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Maturity Onset Diabetes of Youth 
MODY 1 
MODY 2 
MODY3 
MODY4 
MODY5 
MODY6 
Mitochondrial diabetes 
Disease of Exocrine Pancreas 
Cystic fibrosis 
Neoplasia 
Pancreatitis 
Haemochromatosis 
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Endocrinopathies  
Acromegaly 
Cushings syndrome 
Glucoginoma, pheochromocytoma 
Somatostatinoma 
Drug Induced 
corticosteroid 
pentamidine 
thiazides 
beta adrenergic agonist 
antipsycotic 
infections /critical illness 
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Uncommon Forms of Immune Mediated Diabetes 
stiffman syndrome 
type B insulin resistance 
Autoimmune hypoglycaemia 
Genetic Syndrome Associated with Diabetes  
Downs syndrome 
Klienfelter syndrome 
Turner syndrome 
Wolfram syndrome 
Huntington chorea 
Laurence moon biedl syndrome 
Myotonic dystrophy (5) 
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Clinical Features 
Symptoms of hyperglycemia includes  
polyuria 
polydypsia, 
polyphagia, 
weight loss, 
easy fatiguability, 
enuresis in previously toilet trained child 
vaginal candidiasis in prepubertal girls 
Emergency presentation in DKA includes  
dehydration, 
vomiting 
hyperventilation (kussamul respiration) 
altered sensorium, 
abdominal pain, 
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shock, 
hypotension and 
hypoglycemia 
Diagnosis 
According to ISPAD guidelines 
Criteria for diagnosis of diabetes mellitus 
1. Symptoms of diabetes plus casual glucose concentration>11.1mmol/l 
(200mg/dl) 
2. Fasting plasma glucose > 7mmol/l(126 mg/dl) 
3. 2 hr postprandial glucose >11.1mmol/l(200mg/dl) during an OGTT  
(the test to be done as per WHO using a glucose load of 75g 
dissolved in water) (6)  
Glycosylated Haemoglobin 
Glycosylated haemoglobin is a measure of long term glycemic 
control 
This represents fraction of haemoglobin that is nonenzymaticaly 
attached to glucose. Formation of glycosylated haemoglobin is a slow 
process. Depends on blood sugar and continues irreversibly throughout 
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lifespan of RBC’s .High HbA1c means high blood sugar and increased 
exposure of RBCs to glycemic level. 
It reflects glucose concentration in preceeding 2-3 months. Index 
of long term glycemic control. Persistently low value of HBA1C 
indicates good glycemic control. 
It is spuriously elevated in thalassemia and in conditions with 
foetal haemoglobin, and is reduced in sickle cell anaemia. Usually less 
than 6%. Value 6-7.9 % means good metabolic control, 8-9.9 indicates 
fair control, values >10 means poor control. 
The measurement of c- peptide is used to differentiate type 1 from 
type2 Diabetes.  
The etiology of autoimmunity is confirmed by detection of anti 
beta cell antibodies like GAD,IA2, ICA-2,IA 
There are various methods of detection 
ELISA, 
Radioimmunoassay 
Radioligand assay 
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To detect autoantibodies - ELISA with a fusion protein thioredoxin 
produced in E. Coli as antigen is used . c- ELISA showed high 
specificity. p-ELISA is both sensitive and specific .  
Microtiter plate assay for detection of GAD antibodies in type 1 
diabetic patient by using the varelisa anti GAD 11 ELISA, is more 
sensitive and specific.  
GAD -65 antibodies can be detected by simple quantitative 
immunoprecipitation radioligand assay using S35 methionine –labelled 
human islet GAD 65 as antigen . Using this assay it is easy to detect 77% 
of GAD antibody positive patient at onset of disease. 
Investigations in DKA 
random blood sugar, 
urine ketones,  
serum electrolytes,  
 arterial blood gas analysis,  
blood and urine culture,  
urine albumin,  
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renal function test,  
radioimaging and ultrasound abdomen  
 and investigations to rule out sepsis should be done . 
Lab Findings in Diabetic Ketoacidosis 
Due to hyperglycemia 
Glycosuria 
Ketonuria 
Ketoacidosis 
Glucosuria 
Ketonuria /ketonemia 
Anion gap acidosis 
Decreased pH 
Insulin resistance 
high insulin 
increased c-peptide 
elevated adrenal androgens 
elevated liver enzymes 
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Management 
The principle goals are: 
1. metabolic stabilisation 
 
2. avoid acute complications 
3. Prevention of parent and child isolation 
4. Identification and treatment of behavioural dilemmas 
5. education of family to care the child after stabilisation 
6. integration of diabetes routines into school,day care,and family 
activities 
7. maintenance of normal growth and development (7) 
Treatment varies with severity of illness at onset . Treatment varies 
depending on the presence or absence of dehydration. Newly diagnosed 
children without ketoacidosis can be treated with subcutaneous insulin at 
the dose o.3 to 0.5 u/kg /day. Pubertal children require more amount of 
insulin 1-1.5u/kg/day . Usually split /mixed regimen is recommended . 
Insulin regimens using rapidly acting and intermediate acting NPH at 
breakfast and dinner . 2/3 of total dose in the morning one third in 
evening. 2/3 of morning dose as NPH and 1/3 rapidly acting analog . The 
evening dose as ½ NPH and ½ rapid acting analog . Onset of action of 
NPH insulin begins within 2 hrs and peaks at 5-7hrs lasts for 13 -16 hrs. 
Action of Rapidly acting insulin such as lispro and aspart starts at 15 
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minutes peaks at 1-3 hrs and lasts for 3-5 hrs . Short acting insulin should 
be given to maintain target blood sugar level. Thus achieving glycemic 
target without hypoglycaemia. 
Most common lifethreatening and preventable complication of 
diabetes is ketoacidosis. Blood sugar >240mg/ with ketonemia/ketonuria, 
pH <7.3 . As blood sugar >150mg/dl, exceeds renal threshold and causes 
osmotic diuresis resulting in loss of extracellular water and electrolytes. 
Accelerated lipolysis which occurs in insulin deficiency leads to 
conversion of free fatty acids to beta hydroxybutyric acid and acetoacetic 
acid . Intracellular ion potassium is transported from the cell to plasma in 
exchange for hydrogen ion lost in urine.  
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Management of DKA starts with correction of dehydration, 
electrolyte loss, hyperglycemia and acidosis . Initial fluid therapy is 10-20 
ml of 0.9%NS to restore intravascular volume. Maximum < 4 l fluid to be 
given for 48 hrs to prevent cerebral edema. Rehydration fluid should 
contain 115 to135meq/l for gradual decrease in serum osmolality and to 
reduce risk of cerebral edema . Insulin infusion 0 .1u /kg/hr is started . 
Potassium deficit needs aggressive management with 20-60meq of KCL 
added to 1L of fluid . To have a gradual fall in blood sugar by 50-
100mg/dl/hr continous low dose insulin infusion is administered . 
Infusion of insulin should be titrated based on blood sugar. Dextrose 
containing intravenous fluid should be started once blood sugar falls 
below 300mg/dl . If acidosis persists at lower blood sugar level continue 
insulin infusion and dextrose . Don’t infuse sodium bicarbonate for 
correcting acidosis . Stop insulin infusion after correction of acidosis and 
start on subcutaneous insulin 1 hour before stopping insulin infusion and 
then start oral. Monitor blood sugar three times.  
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Insulin Therapy  
Currently there are various methods to deliver insulin . These 
regimens include use of single intermediate or long acting insulin (neutral 
protamine hagedorn) lente, ultralente or glargine given three or four times 
a day or aspart /lispro/ regular insulin as subcutaneuous insulin infusion. 
Type of diabetes, age, glycemic goals, personal choice and 
onset,peak and duration of action determines the selection of insulin 
regimen. There is no estabilised way of measuring insulin requirement in 
type 1 diabetes. Before developing ketonuria, children are initially started 
on insulin at low dose of <.5u /kg per day.  
In children on steroids, puberty, DKA or infection initial dose may 
be as high as 1u/kg . Infants and toddlers may require very low dose. 
Hence for proper dosing, the dose is diluted to 10 u. Diluents are given by 
manufacturers for each specific type of insulin . Goal of therapy is to 
maintain premeal blood glucose value of 80-120mg/dl. Dose of insulin is 
adjusted taking into account the pattern of blood sugar for a period of 3 
days .  
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Usual Subcutaneos Daily Dosage of Insulin in Children and 
Adolescent S With Diabetes 
TYPE NON DKA DKA 
 Type 1 diabetes 
Child,prepubertal 
0.25-.5u/kg/day .5-.75u/kg/day 
Adolescent,pubertal 0.5-.75u/kg/day 0.75-1u/kg/day 
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After few weeks of starting insulin there will be fall in blood sugar 
level and hence requirement of insulin may decrease, this is due to 
residual insulin release called as honey moon phase . In type 1 diabetic 
children due to continued destruction of beta cells, there is increased 
requirement of insulin over weeks and months of treatment and there may 
be decline in growth . Inadequate overnight dosing of insulin results in 
fasting hyperglycemia and ketonuria occasionally . Mixture of rapid and 
intermediate or long acting insulin are given before meal in the morning 
and afternoon to maintain blood sugar level. In adolescent there is rise in 
morning sugar due to afternoon snack . This can be controlled by using 
aspart or lispro insulin .  
Newer insulins are called insulin analogues. They are derived by 
biochemical alteration of the human insulin . This modification causes 
alteration in onset, peak and duration of action . Insulin analogues are 
safe and effective and used for optimal control of blood sugar.  
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First rapid onset insulin analogue is lispro insulin . Onset of action, 
peak and duration of action is designed to reduce postprandial blood 
sugar. So it is ideal to be administered premeal. It’s onset of action is 15 
minutes and duration of action 2-4 hrs. It is easy to titrate insulin in 
erratic eater matching insulin with food intake. Minimises the potential 
for hypoglycaemia. Lispro can be used in very young children as diluents 
are available for lispro insulin.  
Another rapidly acting insulin approved by FDA is aspart insulin. 
Similar onset and duration of action is 4-6hrs. It is not approved for 
children.  
Glargine is long acting insulin analogue. Peakless insulin with 
duration of action being 24 hrs. Mimics the basal insulin produced by 
beta cells.  
It is clear and should be used alone as it is acidic in nature. It is not 
approved for use in children < 6yrs. 
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Premixed insulin preparation containing analogues of lispro and 
intermediate acting insulin is called NPL. It is not used in children as it is 
not possible to alter the dose of individual insulin.  
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Action of Various Types of Insulin 
Insulin Type Onset Peak Duration 
Insulin aspart 5-10min 1-3hrs 3-5 hrs 
Insulin rapid <15minu 30-90minu 2-4hrs 
Regular 30-60min 2-3hrs 3-6 hrs 
NPH 2-4hrs 4-10hrs 10-16hrs 
Lente 3-4hrs 4-12hrs 12-18 hrs 
Glargine 1.1hr No peak 24 hrs 
Ultralente 4-6hrs 8-20hrs 2—24hrs 
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Insulin Delivery Systems  
Most children receive insulin by injection with syringe to provide 
mixing of insulin and flexibility in dose of short acting and long acting 
insulin syringe is calibrated to 3/100cc,1/2cc or 1cc and have 29 gauge 
needle or 30 gauge needle  
Insulin pens with disposable needle tips is more advantageous 
since they offer a discrete, rapid way to administer in children pens are 
available as disposable devices holding 300u . injections interfere with 
lifestyle and there is more risk of hypoglycaemia 
So use of insulin pumps have better glycaemic control, reduce 
hypoglycaemia There is a increasing trend in use of pumps in children 
.insulin pumps provide continuous infusion of insulin over the whole day 
in an effort to maintain basal insulin production .bolus of insulin is 
administered at meals or snacks to maintain normal physiological peaks 
in insulin release in response to food  
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Advantages and Disadvantages of Insulin Pump Therapy 
Advantages Disadvantages 
Greater increased frequency of 
blood sugar  monitoring More incidence of hyperglycaemia 
Intensify the glycaemic control and 
Few hypoglycaemic episode DKA due to crumpled infusion 
Few injection Skin abscess 
Immediate access to insulin Change in hypoglycaemic episodes   constant attachment to pump 
 
Before discharging diabetic children the caretaker should be 
educated about method of blood sugar monitoring, and technique of 
administering subcutaneous insulin. Caretaker should be aware of 
premonitory symptoms of hypoglycaemia  
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Monitoring  
Self Blood Glucose Monitoring  
The patients should perform blood glucose monitoring four to six 
times a day. This empowers patients and their families. It enhances the 
understanding of insulin, food, exercise effects on blood glucose. Real 
time continuous monitoring is expected to be available in future .Target 
range of 80-120mg /dl at breakfast 80-150mg /dl at other times should be 
maintained 80% of blood sugar. If pre breakfast blood sugar is high 
increase the long acting insulin at bed time  
Nutritional Management 
Nutritional consultation is mandatory in newly diagnosed cases to 
encourage them to perform 30-60 minutes of exercise for 5 times a week. 
Calories intake should include 50-55% of carbohydrates, 15 -20% protein 
30% fat. 
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Age Specific Goals 
Hb A1c levels must be adjusted to minimise the frequency of 
hypoglycaemia. Premeal sugar of 100-180mg/dl HbA1C -7.5-8.5 should 
be maintained in toddlers, school children should maintain at 90-
180mg/dl HBA1C -<8% in teenagers blood sugar 80-120mg/dl HbA1C -
<7(3) 
Psychological Aspects 
Evaluation of psychosocial function of child and family is done at 
diagnosis and periodically. Warning signs that needs evaluation includes 
declining school performance, recurrent episodes of DKA, new 
behavioural problems and isolation from friends and activities(1) 
Encourage independence and avoid parent & child conflict 
Hypoglycaemia 
One of the limiting factor in implementation of intensive diabetes 
management is fear of hypoglycaemia. Rapid acting carbohydrate should 
be given during hypoglycaemia, raise blood sugar by 15-20mg/dl after10 
minutes Avoid hypoglycaemia in children as it causes damage to active 
brain. If blood sugar values are <60mg/dl for 3 times in a week reduce 
insulin dose  
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Complications 
Complications of type 1 DM includes retinopathy, nephropathy, 
neuropathy, and cardiovascular disease  
Blood glucose control linked with complications so HbA1C should 
be done at every visit  
  
 
WHEN TO 
COMMENCE 
SCREENING 
FREQUEN
CY 
PREFERRED 
METHOD OF 
SCREENING 
OTHER 
SCREENING 
METHODS 
Retinopathy 
 5 yrs  after 
diagnosis  in 
prepubertal 
children,  pubertal 
children 2 yrs of 
diagnosis 
1-2 yearly Fundal  examination 
Fluorescein 
angiography, 
mydriatic 
ophthalmoscopy 
Nephropathy 
 5 yr 
afterdiagnosis 
prepubertal 
children, after 2 yr 
in pubertal 
children 
Every year Overnight timed urine excretion of albumin 
24-hr excretion of 
albumin,  urine 
albumin/creatinine 
ratio 
Neuropathy Unclear Unclear Physical examination 
Nerve conduction, 
thermal and vibration 
threshold, 
pupillometry, 
cardiovascular 
reflexes 
Macrovascular 
disease After age 2 yr Every 5 yr Lipids Blood pressure 
Thyroid 
disease At diagnosis 
Every 2-3 
yr TSH 
Thyroid peroxidase 
antibody 
Celiac disease At diagnosis Every 2-3 yr 
Tissue 
transglutaminase, 
endomysial antibody 
Antigliadin antibodies 
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Nephropathy 
Urine microalbumin is done annually for nephropathy  
Urine albumin to creatinine ratio if>30mg rule out orthostatic 
proteinuria. 
Microalbuminuria persists angiotensin converting inhibitors can be 
used 
Lipid Profile 
Serum cholesterol and triglycerides are done annually 
Maintain LDL at 100MG /dl  
Pharmacological treatment is given if LDL ->.160mg 
LDL -130-160MG/dl with cardiovascular risk factors 
Opthalmogical Evaluation  
At diagnosis and annually to rule out retinopathy 
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Thyroid Disease 
Type 1 DM children more prone for other autoimmune disease like 
hypothyroidism. Thyroid function test is done at diagnosis then annually 
Celiac Disease  
Anti tissue transglutaminase or antiendomysial antibody at diagnosis 
 
Future prediction, and prevention  
There is long prodromic period before overt disease develops. As 
any other autoimmune disease there is humoral and cellular immune 
response against multiple target antigens .The markers of prediction 
includes glutamic acid decarboxylase antibodies, islet cell antibodies and 
IA2 autoantibodies, insulin autoantibodies and they are detected by 
immunofloresence and radiolig and assay and ELISA  
Type 1 DM is associated with genetic susceptibility gene and the 
major histocompatability complex. More than 95% of cases were 
associated with DR3 /DR4. Restriction fragment length polymorphism 
analysis of DNA from the patients and controls showed stronger 
association 
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Inhaled Insulins  
Administering insulin via respiratory tract either nasally or into 
lungs has developed recently. Three randomised control trials were 
conducted by Cochrane metabolic and endocrine disorders in type 1 
patients. Found that there was no significant difference in HbA1C levels 
on further follow up. There was better glycaemia level in fasting and 
postprandial sugar and less hypoglycaemic episodes side effects was mild 
cough 
Adjunctive Therapies 
Adjunctive therapy were reviewed by Jefferies and colleagues 
Categorised into 3 groups 
Insulin sensitizing agents-biguanides 
Aimed to reduce insulin resistance at puberty 
Agents altering gastrointestinal nutrient delivery 
Acarbose 
Decreases postprandial hyperglycaemia 
Pirenzipine 
IGF-1 
glucagon like peptde  
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Metformin acts by decreasing hepatic glucose output and 
improving insulin sensitivity It decreases HbA1c and can be given at a 
dose of 25-30mg/kg/day. Side effect is gastrointestinal discomfort 
Acarbose is a alpha glucosidase inhibitor . It delays absorption of 
carbohydrate in small intestine and causes 20% reduction in post prandial 
blood sugar and HbA1c level  
Pramlintide (human amylin analog) 
Amylin is a 37 aminoacid peptide secreted along with insulin from 
pancreatic beta cells which regulates gastric emptying and glucose 
delivery to intestine . It inhibits postprandial nutrient stimulated glucogon 
secretion . the trial is done in adult which showed reduction in HbA1c 
and reduction in body weight  
Glucogon Like Peptide  
It inhibits gasric emptying and stimulates glucose dependent 
insulin secretion  
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GAD 65 Antigen Therapy 
Alum formulated GAD 65 was tried in children within 3 months of 
diagnosis. Follow up of these cases was done for 15 months. They found 
that there was no significant change in clinical outcome.(8) 
Prevention  
Primary Prevention  
Aim is to prevent the disease in high risk population before 
serological evidence of islet autoimmunity  
Cows milk protein is associated with T1 DM and breast feeding has 
protective effect. So a case control study was done in children with high 
risk of diabetes and those children who were not given cow milk protein 
and followed up for 10 yrs. At the end of 4 years none of the children in 
control group developed overt diabetes 
 Secondary Prevention 
Delay and possibly suppress beta cell damage 
European nicotinamide diabetes intervention trial, a double blind 
placebo trial was done by administering nicotinamide to first degree 
relatives of T1DM patients with autoantibodies They observed that there 
was no difference in decrease in beta cell function in both groups. So 
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concluded that nicotinamide does not stop the decrease in beta cell 
function  
 Tertiary Prevention  
After onset of disease aimed at inducing prolonged remission  
To preserve remaining beta cell function. reliable screening marker of 
beta cell function is measuring c- peptide  
Anti CD3 -OKT3 is under trial  
Anti CD20 monoclonal antibody – RITUXIMAB  
Pancreas and islet transplantation  
Stem cell therapy gene therapy under trial 
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REVIEW OF LITERATURE  
N.Tandon et al conducted a study in north Indian diabetic children 
to detect prevalence of various autoantibodies. He analysed for GADA, 
IA-2,ICA-12, 21 OH hydroxylase  
Among the101 patients analysed 13.9% were positive for GADA 
with 14.9% showed positive for IA -2. On using radio binding assay to 
detect the antibodies prevalence has increased to 26% 
 Conclusion of this study is that GAD and IA2 antibodies is present 
in 26% of type 1 DM in north India. MMDM patients have >20% 
seropositivity for IA2 antibodies ICA-12 IS prevalent in both type 1 DM 
and MMDM one in every 7 patient shows evidence of coeliac disease(9) 
Urakami .T etal from Nihon university school of medicine, Tokyo, 
Japan conducted a study to compare the prevalence of antibodies to GAD 
and IA--2 at diagnosis in Japanese children  
Among the 108 children analysed, 48 Children were mild form of 
type 1 diabetes and 70 were with early progressive form of type 1 DM, 
both group of children had prevalence of GADA and IA-2A above 70% . 
Children with slowly progressive form of type 1DM had low titres . 
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Titres >100u/ml are frequent in children with RPTID . Antibody titres has 
no significance in clinical form of disease. 
 He concluded that mild form of autoimmunity is associated with 
low titres of antibodies (10) 
 Lee YS etal from National University of Singapore studied the 
prevalence of islet cell antibodies (ICA) and GADA in Asian children 
with DM at diagnosis  
The study concluded that among the 41 children analysed 17 of 
them were positive for ICA and anti –GAD (41.5%). This study also 
compared children with antibodies to without the antibodies on their age 
of onset and random c-peptide levels and HbA1c levels and frequency of 
diabetic ketoacidosis at presentation . There was no significant difference 
in body mass index, age of onset, c- peptide level, HbA1C,and frequency 
of DKA  
This study concluded that prevalence of autoantibodies in 
Singapore children (41.5%) is lower than Caucasian population (60%). 
There is significant proportion of nonimmune mediated type1 DM in 
Singapore children(11) 
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Emad Sabbah etal from university of Oulu analysed 747 children 
with newly diagnosed diabetes for GAD antibodies,IA-2,IAA in relation 
to clinical characteristics and course of disease in children  
Results showed that 73.2% positive for GADA+ 85.7% IA-2A 
54.2% for IAA 72.6%for multiple autoantibodies, 2.3% has no detectable 
autoantibodies. More than one third patient probands tested positive for 
all autoantibodies 36.9% positive for 3 antibodies 18.9% and 6.3% 
positivity was seen in for 2 antibodies and 1 antibody respectively. The 
age of onset in patient positive for GADA is higher than –ve . There was 
no difference in clinical and metabolic characteristics. c-peptide values( 
p- .007) are higher in patients with no autoantibodies children positive for 
IA-CA had low c- peptide levels( p-0.005). multiple antibodies positive 
patient have low serum c-peptide levels p-<.001 and higher insulin dose . 
Antibodies negative patients require less exogenous insulin p<.001 
He concluded that there is no significant difference in degree of 
metabolic decompensation between antibody positive and negative 
patient (12) 
 
45 
 
 Francesco Medici etal from St.Bartholomews Hospital London 
conducted a cross sectional study on antibodies to GAD 65 and tyrosinase 
phosphatase like molecule in fillipino type 1 diabetic patients  
He analysed 91 patients of type 1 DM and 74 type 2 DM and 100 
controls 27% showed GAD positive IA2C positive in 8% in type 1 
diabetic patients. Type 2 DM had neither of two or controls Among these 
positive cases 56% of positivity in seen in cases diagnosed within 2 yrs. 
ICA 2a only in 16%. He compared these results with European patients 
based on age and disease duration found both of them to be similar. 
This study concluded that antibodies to IA 2C is infrequent in 
filipinos and this being the first study to investigate prevalence and 
pattern of humoral immune response in type 1 diabetic patient(13) 
 Claudio Tiberti etal done a study on GAD antibodies and IA-2 
autoantibodies in type 1 diabetic patient saliva. Paired serum and saliva 
were collected and analysed.GAD positive in serum was 64% and in 
saliva 61% positive 
IA -2A positive in serum was 47% and saliva 42%. Detection of 
antibodies in saliva has high sensitivity and specificity.(14) 
Jacob S.Peterson etal had done a study on detection of GAD 
antibodies in diabetes using radioligand assay in Denmark. He used 
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invitro transcribed and translated 35S METHIONINE –labelled human 
islet GAD 65 they concluded that 77% of patients were positive for GAD 
65 antibodies (15) 
Gary T C Kol etal from Australia conducted a study on antibodies 
to glutamic acid decarboxylase in young Chinese diabetic patients. He 
analysed 140 patients based on clinical features, antibodies to GAD and 
pancreatic beta cell function. They concluded that higher prevalence of 
GAD positive (29%) in type 1 diabetic patients P-.003 GAD POSITIVE 
patients have low BMI, early onset of disease, lower blood pressure 
plasma triglyceride and c-peptide.(16) 
David .m Tridgell etal had done a study on interaction of onset 
and duration of diabetes on the percentage of GAD and IA -2 antibody in 
diabetic patients. He analysed 5020 individuals and found that antibodies 
are absent after 5 years of diagnosis . IA-2A positive patients there is no 
significance between onset and duration of disease. In GAD positive 
patients there was significance. 
He concluded that onset and duration of diabetes have significant 
effect on antibody status in GAD positive patients (17) 
C.B.Sanjeevi et al conducted a study on autoimmunity in Indian 
diabetics the study concluded that the prevalence of GAD 65 antibodies 
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in south Indian IDDM patient is 59% and IDDM patient from Cuttack 
have less prevalence for GAD antibodies. It is more prevalent in female 
than male which is pronounced in children <12 years .In Belgian patients 
prevalence of GAD 65 Ab <9years (64%) lower than ICA positive 
patient. ICA 512 associated with rapid rate of disease progression. 
Prevalence of ICA and IAA decreases with increasing age of onset 
prevalence of GAD 65 is unchanged and also included that GAD 65Ab 
have highest diagnostic significance (18) 
Willam .A etal done a study in Swedish children on GAD., islet 
cell antibodies .He analysed 491 newly diagnosed diabetic children for 
GAD antibodies .He observed that there is higher sensitivity and 
specificity for GAD antibodies than ICA and IAA. GAD antibodies are 
more prevalent in females than in males p<.001.GAD65ab were 
associated with DQA1 and IAA with DQA1. There is no seasonal 
variation . Better sensitivity is seen with combining the three antibody. 
GADA were relatively sensitive/specific for diabetes, (19) 
Chao Chen et al had done a study in type 1 DM Chinese patients 
for GAD and protein tyrosine phosphatise antibody. Among the 247 
analysed, majority had persistence of GADA or IA 2A There was a 
decrease in titre of GADA positive from 56% at onset 50.5% at 1 year 
43.3% at 3-5 yrs later. The prevalence of IA -2A were 32.8% 31% and 
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23.3% at 1 year and 3-5years later the median titres were .0825 at 
diagnosis  
He concluded that for diagnosis of various autoimmune disease 
repeated analysis of GADA and IA -2A is necessary (20) 
Aljabra etal had done a study in the in Saudi Patients with Type 
diabetes Mellitus on their prevalence of Autoimune antibodies. Among 
the 171 diabetic patients analysed GADA, ICA and IAA were positive in 
53.22% and 76% respectively. With female preponderance GADA, ICA 
anIAA and those younger than 20 years of age. Children who are positive 
for GADA had higher levels of ICA and IAA than those negative for 
GADA. Multiple antibodies (≥2) were more observed in young patients 
with no gender differences in the prevalence of multiple antibodies . (21) 
K. Das1, A. Shtauvere-Brameus2 etal conducted a study on The 
frequency of GAD65 and ICA512 antibodies in Indian IDDM patients is 
similar to that in Caucasians. The aim was to test whether undernutrition 
is associated with autoimmunity as evidenced by increased or decreased 
autoantibody formation in both clinically diagnosed IDDM and NIDDM 
patients from south India. The prevalence of GAD65 and ICA512 
autoantibodies in controls was 4% and 2%, respectively. On analysing 
131 patients GAD6 5 autoantibodies were present in 73, and ICA512 
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antibodies were present in 41 of patients. The result proved that there is 
no significant difference in prevalence of GAD65 and ICA512 antibody 
in UNDM patients and NNDM patients. The more prevalence of 
autoantibodies among NIDDM on comparing with IDDM in both groups 
suggests high prevalence in slow-onset IDDM. Undernutrition has no 
predisposition for autoimmunity in south Indian diabetic (22) 
Paul Z. Zimmet, etal on the ethnic distribution of  antibodies to 
GAD: and levels in insulin-dependent diabetes mellitus in Europid and 
Asian subjects. The europids had more prevalence of antibodies to GAD 
(63%),and was much lower in Asian populations with IDDM: The 
prevalence amoung Japanese, thai, Korean and Chinese were 
(31%),(29%), (5%) and 27% respectively. There is no difference in mean 
level of antibodies to GAD in all groups, The GAD antibodies are more 
prevalent than islet cell cytoplasmic antibodies. Almost all IDDM 
patients positive for islet cell antibodies had antibodies to GAD, different 
autoantibodies are involved in autoimmune process (23) 
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Sugihara etal conducted a study in Japanese type 1 diabetic 
patients on clinical significance and course of GAD antibodies over time. 
Amoung the patients within 6 months of diagnosis of IDDM, 23 were 
positive. Among the children diagnosed 2 years ago 16 of 49 sera of 
IDDM patients were positive for GADA .  
Controls and NIDDM groups had less prevalence of GADAb than 
cases of IDDM. Other Autoimmune disease like autoimmune thyroiditis 
and congenital hypothyroidism, and was more prevalent in recent-onset 
patients compared to patients with long-standing IDDM. Presence of 
GAD represents an autoimmune response. GADAb had higher prevalence 
in females than in males patients. clinical features including residual 
pancreatic betacell function after diagnosis were demonstrated to be 
similar betweenGADAb-positive and -negative patients. 
 In conclusion, by using the radioimmunoassay (RIA) for GADAb 
revealed a high prevalence of autoimmune reactivity to GAD in Japanese 
IDDM children. These results, using this RIA procedure, might assist in 
laying the groundwork for future trials of immunomodulation therapy for 
IDDM in Japan.(24) 
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C. Lévy-Marchal, J. Tichet conducted a study on islet cell 
antibodies in French children Islet-cell antibodies is reported to be of 
predictive value for the future development of Type 1 (insulin-dependent) 
diabetes in first degree relatives of diabetic patient. Screening for islet 
cell antibodies was done in French schoolchildren (6–17 years) by the 
indirect immunofluorescence technique. Isle. Only 17 sera demonstrated 
islet-cell antibody titre >-24 JDF units. There was no significant 
difference between islet-cell antibody-positive and islet-cell antibody-
negative children. A second blood sample was collected from 80 of 150 
islet-cell antibody positive children after an interval of 8 months. Only 11 
sera have titres < 4.5 JDF for islet-cell antibody titres . HLA-DQB typing 
was performed by restriction mapping techniques in all antibody positive 
and negative patients. There was no significant difference in distribution 
of the susceptibility alleles (DQB1-Asp57-negative) between islet-cell 
antibody-positive and islet-cell antibody-negative children. There is low 
prevalence rate of islet-cell antibody in French schoolchildren, among 
whom the incidence rate of Type 1 diabetes is one of the lowest in 
Europe(25) 
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Lisa Mansson etal conducted a study on Islet Cell Antibodies 
represent autoimmune response against several antigens. They selected 
30 patient serum samples which is positive for ICA and one other 
additional autoantibody such as glutamic acid decarboxylase antibodies 
(GADA), thyrosine phosphatase antibodies (IA-2A) or insulin 
autoantibodies (IAA). The samples were incubated with the specific 
antigen (GAD65, IA-2 or insulin) and the ICA analysis and the 
immunoprecipitation assay were performed before and after the 
absorption. Specific autoantibodies against GAD65 and IA-2 could be 
absorbed with the Corresponding antigen, ten GADA positive and six IA 
2A positive samples became negative after absorption. Low level 
of antibodies was persistent the ICA reaction after absorption . This 
suggest that ICA has immune reaction against not only against beta cells 
but also other  organ specific antigens(26) 
Kaichi Kida, etal had done a study in Japanese patients on in type 
1 diabetic children various autoantibodies like ICA and organ-specific 
autoantibodies There was a decreasing trend in antibodies titres over 
years from 73.15 in the first year, and decreased to 58% 18% 2.8% over 
5, 10 and above 10 years and has no sex predilection . But the prevalence 
of other autoantibodies was in increasing trend and more prevalent in 
female with a significant p- value <.001 
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In some girls there was a rise in titre of antibodies in parallel to a 
decrease in insulin secretion prior to onset of overt IDDM which declined 
thereafter. When asymptomatic autoimmunity is triggered, autoimmunity 
specific to pancreatic islets is triggered and overt disease sets in presence 
of other autoantibodies proves Autoimmunity .(27) 
Dr. C. F. Verge etal had done a study on detect the presence of  
Autoimmunity in type 1 dm children on analysing 273 children with the 
disease to various antibody levels . 
Antibodies assay was done by radioimmunoprecipitation, insulin 
autoantibodies was positive in 176 cases within 4 days of onset of disea 
se by radioimmunoassay, thyroid antibodies assay was done by ELISA 
method antigliadin IgA antibodies by enzyme-linked immunoassay, and 
indirect immunofluroscence was employed to detect anti-endomysial IgA 
and islet cell antibodies . anti-glutamate decarboxylase was positive in 
69%, and 65%,71% 10%, for insulin autoantibodies, islet cell antibodies, 
anti-thyroid peroxidise . Islet cell antibodies and insulin autoantibodies 
were positive respectively Absence of antibodies was seen in13.7% and 
5.8% were negative for all three antibodies and with more prevalence in 
females. 
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There is increase in frequency of antithyroid peroxidase with 
increasing age. Both anti-glutamate decarboxylase and insulin 
autoantibodies rises with rise in ICA Asymptamatic celiac disease 
developed in children with elevations of antigliadin and anti-endomysial 
antibodies .(28) 
 Landin-Olsson M etal had done a population based study for 
prevalence of autoatibodies in newly diagnosed type 1 diabetic children.  
 Children less than 14 years were analysed to various 
autoantibodies results showed 84% predominance in positivity for ICA, 
43% had insulin autoantibodies; both the antibodies positive in 40% . 
Islet cell antibodies positive in 3%, insulin autoantibodies in 1% of 
control group with low positive predictive value of 7% in cases and 4% in 
control group (29)  
T Tuomi, P Björses etal conducted a study on the prevalence of 
autoantibodies in type 1DM patients with autoimmune polyendocrine 
syndrome type I. 6 diabetic patients were positive for GAD65 0.9-8.0 yr 
before the onset of IDDM and in 16 of nondiabetic patients had positive 
antibodies during a follow-up of 2.4-19.5 yr. Nondiabetic patients had 
positivity of 28% for GAD6. Fasting C peptide P = 0.003) and first phase 
ininsulin were lower in patients with than in those without antibodies 
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 In both groups there is no HLA genotype preponderance. 
GAD65-Ab-positive nondiabetic patients, but the IDDM high risk 
genotypes were decreased in frequency among the patients with GAD65-
Ab.  
He concluded, that nondiabetic autoimmune polyendocrine 
syndrome type 1patients have positive for GAD65-Ab together with a 
decreased insulin secretory capacity (30). 
Eba H. Hathout, MD etal had done a study on prevalence of 
Autoimmunity, and HLA Characteristics of Children Diagnosed With 
Type 1 Diabetes Before . The average age of the study patients enrolled 
was 2.6 years, body mass index was 16.9 kg/m2, and weight was 106% of 
average weight for height. On analysing cases with controls body mass 
index showed no significant difference . More prevalence of positive islet 
cell antibodies and glutamic acid decarboxylase 65 antibodies These 
antibodies was significantly less in children with early onset of disease . 
There is no significance in frequencies of diabetes-related HLA 
alleles and haplotypes between the groups. HLA haplotype has negative 
correlation There was a negative correlation with glutamic acid 
decarboxylase(31) 
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H. Barova etal had done a study on AntiGAD positive with type 1 
diabetes mellitus and higher prevalence of autoimmune thyroiditis than 
anti GAD negative patients. His results were anti GAD antibodies was 
found positive in 35%.female to male ratio was1.4 presence of thyroid 
antibodies in 24% of type 1 diabetes with GAD POSITIVE compared 
with GAD negative patients in whom prevalence is 12-4% 
He concluded that there is twice prevalence of thyroid antibodies in 
GAD antibody positive type 1 diabetic patients. Regular examination of 
thyroid and thyroid function test (thyroid antibodies) is essential in type 1 
patients(32) 
Henrik borg etal conducted a study on presence of GAD 
antibodies indicates autoimmunity and its assay in children with recently 
diagnosed diabetes mellitus he studied in 100 children with diabetes and 
controls in diabetic children GAD antibodies was positive in 66 of 
100patients.ICA-was found in 87, IA2-ab in 69% in controls ICA found 
in 2, IA2abin 1 GADA in 3 patient combining IA2-ab and GADA assays 
shows more positivity for autoimmunity  
He concluded that by radioligand binding assay method to detect 
IA2-ab and GADA was positive in 69% of newly diagnosed patients 
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.Though multiple antibodies shows greater frequency, GADA assay is a 
valuable alternative to ICA assay(33) 
Riitta Veijola etal had done a study in HLA dependent genetic 
susceptibility, autoimmunity and metabolic characteristics in finish type 1 
diabetic children with or without affected first degree relatives . He 
analysed 121 familial cases with 574 non familial cases and found that 
frequencies of DQB1 is associated high risk of type 1 diabetes mellitus 
DQB1 is associated with decreased risk for IDDM was less in 
familial cases as comparing nonfamilial cases (32.7vs 21.3%,41.3vs 
35.9%,18.3vs 31.4%and 7.7 vs 11.4% respectively p-0.002). the 
frequencies of various autoantibodies in serum namely glutamic acid 
decarboxylase islet cell antibodies and insulin autoantibodies were similar 
among familial and nonfamilial cases 
31 first affected children were had early onset in familial cases than 
nonfamilial 90 second affected familial cases had no difference in 
familial and nonfamilial cases in metabolic decompensation at diagnosis 
both groups had severe metabolic decompensation . He concluded that as 
there is no significant difference in autoantibody levels between familial 
and nonfamilial cases it indicates homogenity than heterogeneity.(34) 
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Jacob S Peterson etal has done a study on prevalence of islet cell 
autoantibodies in monozygotic and dizygotic Danish twins with type 1 
diabetes mellitus.The results of his study is that prevalence of various 
autoantibodies against beta cells islet cell antibodies ware 38%, 85%,and 
92%respectively in monozygotic twins and 57%,70% and 57% 
respectively in dizygotic twins Among the children with positive for 
antibodies the children without diabetes were 20%, 50% and 40% in 
monozygotic twins and 26%, 49% and 49% in 35 of dizygotic twins 
He concluded that the prevalence of ICA in both types of twins 
were not different, which shows that islet cell autoimmunity is influenced 
by environmental factors than genetic determination. ICA was more 
prevalent in nondiabetic twins than in first degree relative s of patients 
with type 1 diabetes.(35) 
Merrill J Rowley etal had done a study on Antibodies to GAD to 
discriminate Major Types of Diabetes Mellitus. He concluded that The 
frequency of antibody to GAD in IDDM varies from 69%and 59% among 
short-duration and in long-duration cases . Islet cell cytoplasmic antibody 
was positive in patient with disease of longer duration in. Antibodies to 
GAD were elevated in 5% NIDDM cases and in nondiabetic subjects 
were negative for antibodies (36) 
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Eun Gyong Yoo etal had done a study in Korean children on The 
clinical types and characteristics of Diabetes Mellitus . He analysed 177 
diabetic children, grouped as type 1 and 2. All patients with early onset of 
disease were before the age of 9 years were of type 1, initial serum C-
peptide levels were low <0.6(50%), Type 2 had high serum c-peptide 
>1.5ng/dl. There was a change in types on follow up. Only 55.4% of type 
1 DM patients had insulin autoantibody, islet cell cytoplasmic antibody or 
anti-glutamic acid decarboxylase antibodies..  
Results of the study suggest that patients on insulin with positive 
autoantibody are to be classified as type 1 even if their serum C-peptide 
levels are within normal range, and the clinical types could change during 
follow-up.(37) 
J Komulaine etal had done a study on presence of autoantibodies 
andtheir clinical charecteristics in type 1 diabetic children     35 children 
type 1 diabetic <2years 146 were >of age group2-4.9 years and 620 
children  of between 5 to14 years the children with early onset of disease 
had  severe metabolic decompensation  and low c- peptide levels ICA and 
IAA were positive in children <2years  there is no significant difference 
in GAD ANTIBODIES in 3 groups . Strong genetic susceptibility was 
observed  in children<5years.38 
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SIMILAR  STUDIES   IN OUR INSTITUTION 
 
1.Study on  prevalence of thyroid  dysfunction   in type 1 
 diabetic children 
 Results -142 diabetic children were enrolled 
 Among  them 23 (16%)  of diabetic children had overt hypothyroidism 
 12(8%)  children with diabetes had subclincal hypothyroidism 
 Among the diabetic children 
 30(21%)  was positive for thyroid peroxidise  
 21(14%)  positive for   antithyroglobulin 
19(13%)  positive for both the antibodies 
2. Study on the prevalence of vitamin D levels in type 1 Diabetes Mellitus 
 Total of 120 children was studied 
 Mean levels of vitamin D level in the study group was 15.83 ±6.12 
where as in control group  was 18.43 ±4.66ng/dl 
 76%of type 1 diabetic children  had deficient vitamin levels p value 
was.02. 
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AIM AND OBJECTIVES OF THE STUDY 
 
Primary Objective: 
To evaluate prevalence of autoimmunity in type 1 diabetes children  
by detecting GAD antibodies 
 
Secondary Objective: 
To compare the insulin requirement and HbA1C in children with 
GAD antibodies positive and negative new onset diabetic children 
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STUDY JUSTIFICATION 
 
 Wide variation in prevalence of positive for GAD antibodies in 
various population 
 
 Less number of studies in South Indian population  
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MATERIAL AND METHODS 
Methodology 
 
Study Place Institute of Child Health and Hospital for Children, 
Egmore,  
Diabetic Clinic 
Study Design Descriptive 
Study Place Setting Diabetic op in ICH 
Study Period Duration 1 year (August 2013 to August 2014 ) 
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Case Definition 
According to ISPAD guidelines 2011 
Criteria for diagnosis of diabetes 
Symptoms of diabetes plus random blood glucose concentration 
more than 11.1mmol/l (200mg/dl) 
or fasting plasma glucose>7mmol/l >126mg/dl or 
2 hour postload glucose >11.1mmol/l (200mg/dl) during OGTT or 
HbA1c >6.5  
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Study Population 
Inclusion criteria-children with newly diagnosed diabetes between 
age 1 to 12years 
Exclusion criteria- syndromic children 
Sample size- 50 children within one year of presentation 
Ethics 
Institution review board clearance was obtained 
Written informed consent was obtained from the parents of diabetic 
children 
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Manoeure 
This is a descriptive study conducted in Institute of Child Health in 
Egmore, Chennai. We included the diabetic children between the age of 
1-12years who are attending diabetic clinic. After getting informed 
consent from parents children were included in this study 
Diagnosis of type 1 diabetes milletus based on ISPAD Guidelines 
Symptoms plus RBS >200mg/dl 
Fasting blood sugar->126mg/dl 
2 hours post prandial glucose >200mg/dl during oral glucose 
tolerance test  
After conforming the diagnosis and written consent 
Demographic variables like name, age, sex, 
Family history of diabetes present or not are recorded, and 
Physical examination done.  
Whether the child presented as a case of DKA or NDKA if DKA 
first episode or not 
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In case of DKA history recording 
polyuria  
polydypsia, 
polyphagia, 
vomiting abdominal pain 
Breathlessness present or not were noted  
In case of NDKA whether the patients are symptomatic or not 
noted  
Anthropometry including 
Height, 
Weight, 
BMI and Recorded.  
BP is recorded. 
Presence of vitiligo, acanthosis nigricans, 
Thyroid swelling present of not 
68 
 
After explaining the procedure 2ml of venous blood was taken 
from cases and presence of GAD autoantibodies in serum was tested by 
ELISA method HbA1c, thyroid profile. serum cholesterol were obtained 
from records 
Age was categorised into 4 groups children between 1-3 yrs,4-6yrs,  
7-10yrs, >10yrs 
Sex categorised as male and female. 
Family history categorised as positive and family history negative.  
Positivity for GAD antibodies was analysed  
titre more than 10 iunits considered as GADA positive -1.  
GADA negative – titre less than 10 iunits 
Hb A1c measured value is categorised into values <8 as good 
control and  >8 as poor control. 
Requirement of insulin is categorised based on body weight as 
requirement less than 1u/lkg or more than 1 unit per kgThyroid status is 
categorised as normothyroid or hypothyroid. 
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After calculating the percentage 95% confidence interval is 
calculated using this formula 
p ±1.96*ඥ݌(1 − ݌)/݊ 
p=0.42 
n=50 
on applying this formula 95% confidence interval is calculated 
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STATISTICAL ANALYSIS 
The datas were entered in excel sheet  
  Proportion will be calculated 
 Comparison of study parameters with patient  
Who are positive for GAD antibodies and negative 
Statistical analysis of data will be performed by statistical software SPSS 
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RESULTS 
 
50 children with newly diagnosed diabetes mellitus attending 
diabetic clinic were analysed for presence of GAD antibodies.  
 
The following were the characteristics of study population  
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AGE DISTRIBUTION 
  
  
 On analysing the 50 children with diabetes 4 children were 
between 1-3 yrs and 16 children between 4-7 yrs, 12 children 
between8-10yrs and 18 belong to age group more than 10yrs 
  
Age Number Percentage 
1-3yrs 4 8 
4-7yrs 16 32 
8-10yrs 12 24 
>10yrs 18 36 
Total 50 100 
73 
 
  
  
4,
(8%)
16,
(32%)
12,
(24%)
18,
(36%)
0
2
4
6
8
10
12
14
16
18
20
1-3 yrs 3-6 yrs 6-10 yrs >5 yrs
AGE DISTRIBUTION
74 
 
SEX DISTRIBUTION 
  
 On analysing the gender distribution 24 of them were male and 26 
of them were female shows near equal distribution  
 Sex ratio 1:1.1 
  
 
 
 
 
Sex Number Percentage 
Male 24 48 
Female 26 52 
Total 50 100 
75 
 
 
 
 
 
  
24,
(48%)
26,
(52%)
SEX DISTRIBUTION
male female
76 
 
 
 
FAMILY HISTORY 
 
Family history Number Percentage 
Present 10 20 
Absent 40 80 
Total 50 100 
 On analysis based on their family history only 10 among of them 
had positive family history and 40 of them had negative family 
history 
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INITIAL PRESENTATION 
 
 
 More than 75% of them presented with diabetic ketoacidosis 
and only 24 % presented as non diabetic ketoacidosis 
 
 
Initial Presentation Number Percentage 
DKA 38 76 
NONDKA 12 24 
TOTAL 50 100 
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PRESENCE OF GAD ANTIBODIES 
  
 
 The prevalence of GAD antibodies in our study was 42% with 
95% confidence interval of 56 -28.  
 GAD antibodies Number Percentage 
Positive 21 42 
Negative 29 58 
 50 100 
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 Among the 50 patients analysed 21 were GAD positive and 29 
were GAD negative  
  
21,
(42%)
29,
58%
PRESENCE OF GAD ANTIBODIES
GAD +ve GAD -ve
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Hb A1C VALUES OF CHILDREN  
HbA1C values Number 
<6 7 
6-8 4 
8-10 10 
>10 29 
 
 
 Majority of children had high HbA1 C ( >10) 
  
83 
 
 
 
 
  
7
4
10
29
0
5
10
15
20
25
30
35
<06 6-8 8-10 >10
Hb A1C VALUES OF CHILDREN 
84 
 
 
 COMPARISON OF GAD POSITIVE WITH AGE 
DISTRIBUTION 
Age Interval 
Gad Antibodies 
Total 
Positive Negative 
1-3yrs 3 1 4 
4-6yrs 4 12 16 
7-10yrs 6 6 12 
>10yrs 11 7 18 
 24 26 50 
 
 On analysing the age distribution with GAD antibodies, among the  
children with positive for GAD antibodies18 children were 
more than 10 years   
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COMPARISON OF AGE DISTRIBUTION WITH 
PRESENCE OF GAD ANTIBODIES 
 
 
 
  Children above 10 Years have higher prevalence 
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COMPARISON OF SEX DISTRIBUTION WITH GAD 
ANTIBODIES 
 
Sex GAD ANTIBODIES 
Total 
 Positive Negative 
Male 12 12 24 
Female 9 17 26 
 21 29 50 
 
 On comparing sex distribution with presence of  GAD antibodies 
positive cases are more prevalent in male children 
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COMPARISON OF SEX DISTRIBUTION WITH GAD 
ANTIBODIES 
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COMPARISON OF GAD ANTIBODIES WITH HbA1C 
HbA1C GAD+ve GAD-VE TOTAL 
<8 4(36%) 7(63.6%) 11 
>8 17(43.6%) 22(56.4%) 39 
TOTAL 21 29 50 
 
 
 On calculating p- value using chi –square  
 P value -0.184 (>0.05) 
 So not significant 
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COMPARISON OF GAD POSITIVE WITH HbA1C 
 
 
 
 The median value of HbA1c in GAD positive patients was11.0 and 
interquartile was 5.15 
 
 The median value of HbA1c in GAD negative patients was 10.3 and 
interquartile was 4.35 
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COMPARISON OF INSULIN REQUIREMENT WITH 
POSITIVE FOR GAD ANTIBODIES 
Insulin 
requirement GAD +ve GAD -ve  
<1unit 7 7 14 
>1unit 14 22 36 
total 21 29 50 
 
  
  Calculating p value by chi square test 
  P value-0.31(>0.05) 
  So p value is insignificant 
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COMPARING INSULIN REQUIREMENT WITH GAD 
ANTIBODIES 
 
 
 
 On comparing insulin requirement with GAD,in children with GAD 
POSITIVE median value was1.3 and interquartile was90 
  In GAD NEGATIVE median value was 1.45 and interquartile was 
80  
  
92 
 
DISCUSSION 
 
In our study we analysed 50 newly diagnosed type 1 diabetic 
children attending our diabetic clinic.  
On analysing prevalence of GAD antibodies  
 In our population the prevalence was 42%  
 Prevalence of type 1 diabetes was high in children 
above10 years of age. 
 There is no significance in family history.  
 HbA1c values were high at presentation  
 Even though there is clinical significance in insulin 
requirement in GAD positive and negative patient 
statistically there is no significance in insulin requirement  
 There were only 2 children with thyroid swelling.  
 One among them had low T3 and TSH and thyroid 
antibodies positive 
On comparing our study with a study done by Lee etal from 
Singapore children for prevalence of GAD antibodies the results are 
similar to our study 41 % had GAD antibodies positive but age of onset 
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was 7yrs but our study concluded that peak age of onset was > 10 years 
and high HbA1c 
 Similar studies done in finland children on prevalence of 
antibodies in diabetic children.  
 The results were 73.2% were GAD positive 85% for IA2A 
54%IAA younger children were positive for multiple antibodies 
p<0.001 
 The prevalence is high compared to our study  
 There was no significant difference in metabolic decompensation 
at diagnosis in children with GAD positive and negative patients 
Another study done among finland children showed  
 73% had GAD antibodies positive and 85,7% for IA -2A 54.2% 
for IAA  
 on comparing with our study the prevalence rate is high  
 There is no significant in degree of metabolic decompensation at 
diagnosis which is similar to our study 
 Antibodies negative individuals have low insulin reqirement 
compared to positive individuals 
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 An author named Francesco had done a similar study in Filipino type 1 
diabetic patients  
 He analysed 91 patients by cross sectional study  
 27% were positive for GAD antibodies within 2 years of 
diagnosis  
 In recently diagnosed patients positivity has raised to 56%  
 on comparing with our study the prevalence is high 
A study done in Chinese patients  
 The prevalence of GAD antibodies in insulin deficient patients is 29% 
On comparing with our study the prevalence of GAD antibodies is low 
Similar study in north Indian population showed that  
 Prevalence of GAD antibodies and IA 2 was 26%  
 Prevalence is less compared to our study 
William a. Hagoplan has done a study in Swedish children s 
 The sensitivity and specificity was70 /96 % for GAD antibodies 
84/96% for ICA, for IAA 93/93% 
 Compared to our study there is high prevalence in Swedish children 
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An author A.K.Das had done a study on gad65 and ICA512 
antibodies in undernourished and normally nourished south Indian 
patients he concluded that patients with onset <5years duration was 55% 
which is higher than in our study 
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COMPARISON OF GAD ANTIBODIES IN VARIOUS 
STUDIES 
Lee et al 40% 
N.Tandon et al 26% 
Urkami et al 70.8% 
Emad sabbah et al  73.2% 
Francesco et al 27.4% 
Gary et al 12.1% 
 William A hagoplan 96% 
Chao chen et al 56.3% 
Henrik borg et al 38%, 57% in mono and dizygotic twins 
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This is a prime study done in a tertiary care center in south Indian 
children with diabetes. Considering that the disease is rare in children 
sample size is limited .  
Presence of GAD autoantibodies implies autoimmune etiology of 
the disease 
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CONCLUSION 
GAD antibodies was present in about 42% of South Indian type 1 
diabetes mellitus 
There is no correlation with metabolic derangement and presence 
of GAD antibodies  
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LIMITATIONS 
 Limited Sample size  
 
  Only a single antibody assay was done 
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RECOMMENDATIONS 
  
 Larger sample size can be achieved by multicentric study 
 
 Other antibodies like IAA, ICA, anti thyroid antibodies 
autoantibodies level can be analysed 
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ABBREVATIONS 
 
        DM – Diabetes Mellitus  
        GAD – Glutamic  Acid  Decarboxylase 
       IAA – Insulin Associated Antibodies  
        ICA   - Islet Cell Antibodies 
        DKA- Diabetic ketoacidosis 
       NDKA-  Non Diabetic Ketoacidosis 
       IDDM- Insulin Dependent Diabetes Mellitus 
       NIDDM-  Non Insulin Dependent Diabetes Mellitus  
        MHC- Major  Histo compatibility 
  
  
 
  
  
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
  
 
 
 
 
  
 
 
  
  
 
KEY WORDS TO MASTER  CHART 
 Age  
1-3years- 1 
3-6 years-2 
 6-10 years -3 
 >10 years 4  
 Sex 
 Male -1  
-female -2 
 Family history 
  positive family history -1 
  Negative history-2 
Initial presentation  
 Dka -1  
 Ndka-2 
 Presence of  GAD antibodies 
 Positive-1 
Negative -2 
 Presence of thyroid swelling -1  
no thyroid swelling -2 
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1 rajkiran Y 2 male 1 no 2 Y 2 y y y no no 2 11.9 1.7units 2 yes 
2 kavya y 2 female 2 no 2 y 1 y y y no no 2 13.7 1unit 1 yes 
3 suchitra y 3 female 2 no 2 y 1 y y y no no 2 11.5 1.8unit 2 yes 
4 swetha y 1 female 2 yes 1 y 2 y y y no yes 1 10.6 .6units 1 yes 
5 chandru y 3 male 1 yes 1 y 1 y y y no yes 1 7.8 1.9unit 2 yes 
6 karthick y 1 male 1 no 2 y 1 y y y no no 2 9.3 1unit 1 yes 
7 anitha y 4 female 2 no 2 y 1 y y y no no 2 6.5 1.5unit 2 yes 
8 surya y 4 male 1 no 2 y 1 y y y no yes 1 7.8 1.4unit 2 yes 
9 abinaya y 2 female 2 no 2 y 1 y y y no no 2 5 2.1unit 2 yes 
10 angel y 2 female 2 no 2 y 1 y y y no no 2 10.3 1.1unit 2 yes 
11 silambarasi y 3 female 2 no 2 y 2 y y y no yes 1 17.3 .5unit 1 yes 
12 thamman y 2 male 1 no 2 y 1 y y y no no 2 7.1 3.1unit 2 yes 
13 arulmurugan y 2 male 1 no 2 y 1 y y y no yes 1 15-Jan 1.6unit 2 yes 
14 sanjay y 2 male 1 yes 1 y 1 y y y no yes 1 11.9 1.3units 2 yes 
15 sathish y 3 male 1 no 2 y 1 y y y no yes 1 8 1.1units 2 yes 
16 hasmitha y 2 female 2 no 2 y 1 y y y no no 2 11.2 1.8units 2 yes 
17 harini y 4 female 2 no 2 y 1 y y y no yes 1 11-Jan 1.3units 2 yes 
18 nivaspandy y 2 male 1 no 2 1 y y y no no 2 10 1.6unit 2 yes 
19 kalaiyarasan y 3 male 1 no 2 y 1 y y y no no 2 10.7 1.3units 2 yes 
2o sri y 3 female 2 no 2 y 1 y y y no yes 1 6.3 2.25unit 2 yes 
21 akash y 4 male 1 yes 1 y 1 y y y no yes 1 17.4 3.6units 2 yes 
22 madhyumitha y 1 female 2 no 2 y 1 y y y no yes 1 9.5 .4 units 1 yes 
23 ashokkumar y 4 male 1 no 2 y 1 y y y no yes 1 11.5 1.3units 2 yes 
24 sukumar y 4 male 1 no 2 y 1 y y y no yes 1 14.8 1.7units 2 yes 
25 sivakami y 4 female 2 yes 1 y 1 y y y no yes 1 14.5 1.9units 2 yes 
26 lavanya y 4 female 2 no 2 y 1 y y y no yes 1 9.2 .6units 1 yes 
27 bavadharani y 4 female 2 no 2 y 2 y y y y no no 2 8.2 .44units 1 yes 
28 joshu franklin y 1 male 1 no 2 y 1 y y y no no 2 8.3 3units 2 yes 
29 sreevishal y 3 male 1 no 2 y 2 y y y no yes 1 13.6 1.2units 2 yes 
30 venkatesh y 4 male 1 no 2 y 1 y y y no yes 1 8.6 1.9units 2 yes 
31 satheesh y 2 male 1 no 2 y 1 y y y no no 2 12.3 1.6units 2 yes 
32 saranya y 3 female 2 yes 1 y 1 y y y no no 2 16.9 .9units 1 yes 
33 sreesha y 4 male 1 no 2 y 2 y y y no yes 1 10.3 1.4units 2 yes 
34 swathy y 2 female 2 no 2 y 1 y y y no no 2 14.3 2.9units 2 yes 
35 veeramani y 3 male 1 no 2 y 2 y y y no no 2 5.7 .6units 1 tes 
36 syed sherif y 3 male 1 no 2 y 2 y y y no no 2 11.2 .9units 1 yes 
37 shylaja y 4 female 2 no 2 y 1 y y y no no 2 8.9 1.4units 2 yes 
38 aruna y 2 female 2 no 2 y 2 y y y no no 2 9.2 .7units 1 yes 
39 sabithra y 4 female 2 yes 1 y 2 y y y no no 2 5.4 1.8units 2 yes 
40 shreja y 4 female 2 no 2 y 2 y y y no no 2 5 1.1units 2 yes 
41 abinsree y 4 female 2 no 2 y 1 y y y yes no no 2 12.1 2.4units 2 yes 
  
 
42 aiswarya y 4 female 2 no 2 y 1 y y y no yes 1 11.7 1unit 1 yes 
43 vignesh y 4 male 1 no 2 y 1 y y y no no 2 6.3 1.5units 2 no 
44 divya y 2 female 2 yes 1 y 1 y y y no no 2 11.7 1.4units 2 yes 
45 mohanapriya y 3 female 2 no 2 y 1 y y y no yes 1 9.5 .8units 1 yes 
46 venkatkarthick y 3 male 1 yes 1 y 1 y y y no no 2 15.7 1.45units 2 yes 
47 sivapriya y 2 male 1 no 2 y 1 y y y no no 2 9.5 .86units 1 yes 
48 jamuna y 2 female 2 no 2 y 1 y y y no no 2 15.7 1.45units 2 yes 
49 princy y 4 female 2 yes 2 y 1 y y y no yes 1 11 1.6units 2 yes 
50 vinaykumar y 2 male 1 no 2 y 1 y y y no no 2 11 1.2units 2 yes 
 
